1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
(
- Contribution to journal › Article
- 2021
-
Mark
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib
(
- Contribution to journal › Article
- 2010
-
Mark
Different molecular behavior of CD40 mutants causing hyper-IgM syndrome.
(
- Contribution to journal › Article
- 2008
-
Mark
The EUROclass trial: defining subgroups in common variable immunodeficiency.
(
- Contribution to journal › Article
- 2002
-
Mark
Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
(
- Contribution to journal › Article
- 2001
-
Mark
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations
(
- Contribution to journal › Article